FDA to Ban Asthma Inhalers That Contain CFCs

by Kathy Jones on  September 24, 2011 at 4:30 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

The US Food and Drug Administration confirmed that it is going ahead with the ban on asthma inhalers that use chlorofluorocarbons (CFCs) since it harms the environment.
 FDA to Ban Asthma Inhalers That Contain CFCs
FDA to Ban Asthma Inhalers That Contain CFCs

The health agency had agreed to phase out such inhalers back in 2008 and has now revealed that the ban will come into effect from next year. The decision means that the only over-the-counter asthma inhaler, Primatene Mist, will not be available from next year.

Primatene Mist, manufactured by Armstrong Pharmaceuticals, is the only such inhaler marketed in the United States and is thought to be used by more than a million asthma patients in the country.

The FDA added that all inhalers that contain the drug epinephrine will be banned starting from next year. Two other prescription inhalers that make use of the drug; Boehringer Ingelheim's Combivent Inhalation Aerosol and Graceway Pharmaceuticals' Maxair Autohaler., will also be phased out by the end of 2013.


Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Childhood Asthma Asthma Remedies for Seasonal Allergy Relief Allergy - Symptom Evaluation Wheezing Churg-Strauss Syndrome Tests for Asthma Stay Well This Winter 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive